TITaichi Ishiguro

Taichi Ishiguro

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Taichi Ishiguro has a total of 83 co-authors. Here are the top co-authors by number of shared publications:

  • Takakazu Kawamata

    Department of Neurosurgery, Tokyo Women’s Medical University Hospital, Tokyo, Japan

    9 shared publications
  • Yoshihiro Omura

    Department of Neurosurgery, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan

    5 shared publications
  • Kenichi Hodotsuka

    Department of Neurosurgery, Moriya Dai-ichi General Hospital, Moriya, Ibaraki

    4 shared publications
  • Kostadin Karagiozov

    Department of Neurosurgery, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan

    4 shared publications
  • Mana Suzuki

    Department of Neurosurgery, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan

    4 shared publications
  • Masato Murakami

    Department of Neurosurgery, Tokyo women's medical university hospital, Tokyo, Japan

    4 shared publications

Latest Publications

  • Roles of Sirtuin-1 in the Prevention of Intracranial Aneurysm Rupture in Mice

    by Hiroki Sato, Taichi Ikedo, Yushiro Take, Tetsuro Kimura, Takeshi Miyamoto, Daisuke Kudo, Redi Rahmani, Taichi Ishiguro, Hiroki Uchikawa, Takuma Maeda, et al.

    BACKGROUND: SIRT1 (sirtuin-1) regulates various cellular and metabolic processes in the vasculature. SIRT1 is an NAD + -dependent deacetylase that deacetylates transcription factors that control vascular inflammation and remodeling. Given that pathways regulated by SIRT1 are implicated in the pathophysiology of intracranial aneurysms, we hypothesized that activation and overexpression of SIRT1 prevent aneurysm rupture by suppressing vascular inflammation. METHODS: Intracranial aneurysms were induced in mice by systemic hypertension and a single intracisternal injection of elastase. We analyzed the expression of SIRT1 in human and mouse aneurysms. We investigated the role of SIRT1 in aneurysm rupture using genetic overexpression of SIRT1 and cell-specific deletion in the endothelial, vascular smooth muscle, and myeloid lineages. We administered a SIRT1 activator and a SIRT1 inhibitor to assess the rupture rate and mRNA expression in cerebral arteries. RESULTS: SIRT1 expression was significantly lower in intracranial aneurysm tissues than in control cerebral arteries in mice, with a similar trend in human aneurysms. Global overexpression of SIRT1 significantly decreased the rupture rate. Endothelial SIRT1 deletion increased the rupture rate, with no effect observed in other cell types. Inhibition of SIRT1 increased the rupture rate, whereas SIRT1 activation reduced the rupture rate and suppressed mRNA expression of proinflammatory cytokines in cerebral arteries. CONCLUSIONS: Our findings support a protective role of SIRT1 against intracranial aneurysm rupture in mice, with endothelial SIRT1 playing an important role in aneurysm stabilization. Pharmacological SIRT1 activation reduced aneurysm rupture and was associated with reduced vascular inflammation, providing a preclinical rationale for further investigation of SIRT1-related pathways.

  • Loss‐Of‐Function CCM Gene Variants in Japanese Patients With Cerebral Cavernous Malformations

    by Takahiro Hori, Satoshi Tsutsumi, Kazutoshi Hashimoto, Taichi Ishiguro, Hidenori Ohbuchi, Yasunaga Yamamoto, Emi Nomura, Kenko Azuma, Yuichi Kubota, Hiroyuki Akagawa

    Hereditary cerebral cavernous malformations (CCMs) are characterized by lesion multiplicity and the formation of de novo lesions, in contrast to sporadic forms. We performed sequencing analyses covering the known autosomal dominant loci CCM1/ KRIT1 , CCM2/ CCM2 ( Malcavernin ), and CCM3/ PDCD10 in 11 patients from eight families with CCMs. All patients had multiple lesions, and de novo lesions were observed in four patients (36.4%). Heterozygous loss‐of‐function variants were identified in seven families, including four variants of KRIT1 , two of CCM2 , and one of PDCD10 . Among them, c.1730 + 4_1730 + 7delAGTA in KRIT1 and c.609G>A (p.Lys203=) in CCM2 were putative splicing variants located outside the invariant GT/AG dinucleotides at the splice junction because AI‐based prediction tools indicated that both variants may disrupt normal splicing. In vitro splicing assays confirmed that the AI‐based predictions were correct, and the same aberrant splicing pattern was reproduced by reverse transcription PCR using tissue‐derived RNA for the c.609G>A variant in CCM2 . In one patient with numerous CCM lesions, whole‐genome sequencing was performed, which showed no abnormalities in the three known CCM loci, including deep intronic and structural variants. This may indicate the technological limitations of current bioinformatics analyses or the presence of a novel CCM gene.

  • Top Cited Papers
    Open Access

    Low radial and axial force stent retriever reduces symptomatic subarachnoid hemorrhage after mechanical thrombectomy for acute middle cerebral artery and medium vessel occlusion: a prospective pilot study

    by Taichi Ishiguro, Yoshihiro Omura, Yuki Takano, Takashi Arai, Kostadin Karagiozov, Kotaro Fukuda, Yoshichika Kikuta, Nobuhiko Momozaki, Hiroki Eguchi, Masahiko Nishitani, et al.

    Background: Subarachnoid hemorrhage (SAH) is a well-recognized complication after mechanical thrombectomy (MT) and may adversely affect clinical outcomes. SAH commonly results from vessel injury due to overextension or displacement during device retrieval. This risk is particularly concerning in smaller, tortuous vessels, such as in medium vessel occlusions (MeVO). This study evaluated whether a novel low radial and axial force stent retriever (Tron FX II) could reduce post-procedural SAH without compromising recanalization outcomes. Methods: The study comprised two components: (1) bench testing comparing radial/axial force and vessel displacement during retrieval between Tron FX II (hereafter Tron) and conventional devices; and (2) a prospective observational study of 197 consecutive MT patients. A combined technique was employed in all cases. Conventional stent retrievers were used until July 2023, after which Tron was used exclusively. Post-procedural SAH was assessed using dual-energy CT immediately after MT. The primary outcome was SAH incidence, with or without symptoms. Secondary outcomes included effective recanalization, first-pass rate, and 90-day functional outcomes. Results: Bench testing showed Tron exhibited the lowest radial/axial force and the smallest vessel deviation during retrieval. Clinically, Tron significantly reduced the incidence of post-procedural SAH (7.7% vs. 23.9%, p = 0.027) as well as SAH associated with neurological deterioration (1.9% vs. 12.7%, p = 0.044) in cases of middle cerebral artery occlusion (MCAO) and MeVO. Moreover, both Tron use and fewer stent retriever passes were independently associated with a lower risk of SAH. Overall effective recanalization, first-pass rates, and functional outcomes were not significantly different between groups in this pilot study. Conclusion: The low radial and axial force stent retriever reduced post-procedural SAH while maintaining effective recanalization when combined with an aspiration catheter. These findings support its potential role as a safer option for MCAO and MeVO.


  • Open Access

    Postoperative watershed shift induced ischemic stroke after direct revascularization surgery in chronic intracranial atherosclerotic steno-occlusive diseases; case series and literature review

    by Masahiko Nishitani, Taichi Ishiguro, Shunsuke Nomura, Yoshihiro Omura, Kostadin Karagiozov, Tadasuke Tominaga, Nobuhiko Momozaki, Mana Suzuki, Akitsugu Kawashima, Takakazu Kawamata

    Background: Extracranial-intracranial (EC-IC) bypass surgery is performed to reduce the risk of ipsilateral cerebral infarction in selected patients with chronic intracranial atherosclerotic steno-occlusive disease (ICAD) with reduced cerebral blood flow (CBF). However, postoperative watershed shift induced ischemic stroke (WSIS) may occasionally occur despite maintained bypass patency and improved CBF. We report the incidence and characteristic features of WSIS after superficial temporal artery-middle cerebral artery (STA-MCA) bypass for chronic WSIS. Methods: We retrospectively analyzed 158 patients with symptomatic chronic ICAD and impaired CBF and cerebrovascular reactivity who underwent STA-MCA bypass between 2013 and 2023. Clinical data and pre- and postoperative imaging findings were analyzed to identify WSIS. Results: Postoperative bypass patency was 100%. Ischemic complications occurred in 3 of 158 patients (1.9%), all of which were WSIS. Notably, 3 WSIS cases occurred in patients with severe internal carotid artery stenosis. These infarctions occurred on postoperative day 3, despite good bypass patency. Angiography confirmed bypass flow supplied the entire MCA, but anterograde ICA flow was consequently reduced, leading to a hemodynamic shift. Conclusions: WSIS is a rare (1.9%), but important complication after STA-MCA bypass, occurring in patients who have preserved anterograde flow preoperatively.

  • Open Access

    Feasibility of endovascular treatment for fetal-type posterior cerebral artery aneurysm with P1 segment aplasia: illustrative case

    by Jun-Ichi Nomura, Taichi Ishiguro, Kenichi Hodotsuka, Takakazu Kawamata

    BACKGROUND: Aneurysms of the fetal-type posterior cerebral artery (FPCA) are rare and often present with fusiform or dissecting morphology. Unlike the adult-type posterior cerebral artery (PCA), the FPCA can only be accessed through the internal carotid artery, limiting endovascular routes and device options. These anatomical and technical constraints often necessitate parent artery occlusion (PAO) as a treatment strategy; however, it carries a substantial risk of ischemic complications. The authors report a rare case of a ruptured FPCA aneurysm with ipsilateral P1 segment aplasia, treated successfully with stent-assisted coil embolization with preservation of anterograde FPCA flow. OBSERVATIONS: A 79-year-old woman presented with subarachnoid hemorrhage and impaired consciousness. Imaging revealed a fusiform aneurysm along the FPCA and aplasia of the ipsilateral P1 segment. Because of narrow vessel anatomy, dual microcatheter techniques were not feasible. After conservative management, the patient underwent stent-assisted coil embolization via a transcellular approach. The aneurysm was completely obliterated with preserved FPCA flow, and no ischemic complications occurred. LESSONS: A literature review suggests that aneurysms with saccular configuration and proximity to the P2 segment are favorable for selective coil embolization. Given the high risk of thalamic and occipital infarction associated with PAO, preserving FPCA flow should be prioritized when anatomically and technically feasible. https://thejns.org/doi/10.3171/CASE25556


  • Open Access

    Infected aneurysm of middle meningeal artery causing intracerebral hemorrhage: illustrative case

    by Mana Suzuki, Taichi Ishiguro, Yoshihiro Omura, Kostadin Karagiozov, Keita Yoshida, Tadao Nakazawa, Tadasuke Tominaga, Nobuhiko Momozaki, Masahiko Nishitani, Takakazu Kawamata

    BACKGROUND: Middle meningeal artery (MMA) aneurysms are rare and typically associated with trauma. Nontraumatic MMA aneurysms are very rare, and their rupture can lead to intracranial hemorrhage. OBSERVATIONS: The authors present a case of a ruptured MMA aneurysm causing intracranial hemorrhage in the temporal lobe, for which immediate hematoma evacuation and aneurysm resection were performed. Pathological examination revealed severe inflammatory infiltration and destruction of the aneurysm wall, consistent with an infected aneurysm. Additionally, they conducted a systematic search and literature review of previously reported cases of nontraumatic MMA aneurysms to identify their characteristics. Data from 33 published cases were extracted and summarized. Nontraumatic MMA aneurysms are rare, with sporadic reports linking them to hemodynamic stress. There were only a few cases linked to infectious etiologies. In the illustrative case, inflammation from periodontal disease likely spread to the MMA, leading to aneurysm formation and rupture. This case underscores the potential for devastating outcomes in infected MMA aneurysms and highlights the need for prompt diagnosis and treatment. LESSONS: Although nontraumatic MMA aneurysms are extremely rare, their rupture necessitates immediate medical intervention due to the risk of fatal intracranial hemorrhage. https://thejns.org/doi/10.3171/CASE25214


  • Accuracy and usefulness of dual-energy computed tomography after mechanical thrombectomy: A retrospective study

    by Yuki Takano, Taichi Ishiguro, Kotaro Fukuda, Masato Murakami, Kostadin Karagiozov, Yoshichika Kikuta, Takashi Arai, Hiroki Eguchi, Makiko Sakaguchi, Takakazu Kawamata


  • Open Access

    Utilizing Argatroban for Neuroendovascular Therapy in Heparin-Induced Thrombocytopenia: A Case Report and Technical Review

    by Hiroki Eguchi, Taichi Ishiguro, Yoshihiro Omura, Yuki Takano, Takashi Arai, Nobuhiko Momozaki, Kostadin Karagiozov, Masahiko Nishitani, Makiko Sakaguchi, Mana Suzuki, et al.

    Objective: Heparin-induced thrombocytopenia (HIT) is a prothrombotic, immune-mediated complication of heparin therapy. In urgent neuroendovascular procedures, alternative anticoagulation strategies are crucial for mitigating thrombotic risk. Argatroban is a potential substitute; however, its use in neurointervention remains limited. This report describes a case of successful endovascular retreatment using argatroban in a patient with active HIT and includes a literature review to clarify optimal administration protocols, dosages, and monitoring strategies.Case Presentation: A 77-year-old man with dural arteriovenous fistula (dAVF) developed HIT following initial endovascular embolization. Due to recurrent cortical venous reflux and a high risk of rebleeding, urgent retreatment was performed using argatroban. An intermittent bolus strategy was employed, with dosing adjusted every 30 minutes based on activated clotting time (ACT) to maintain ACT ≥200 seconds. Complete shunt obliteration was achieved without any ischemic or hemorrhagic complications. HIT antibodies became negative 3 months later.Conclusion: Argatroban is a viable and safe alternative to heparin in neuroendovascular procedures for patients with HIT. Intermittent bolus administration guided by ACT offers precise, situation-specific control and may be particularly appropriate for hemorrhagic cerebrovascular conditions such as dAVFs.


  • Open Access

    Middle meningeal artery embolization for chronic subdural hematoma: a systematic review

    by Yoshihiro Omura, Taichi Ishiguro

    Background: Chronic subdural hematoma (cSDH) is one of the most common diseases in neurosurgery. Middle meningeal artery embolization (MMAE) is reportedly an option to prevent recurrence or avoid surgery in patients with cSDH. This study was performed to review the evidence on MMAE for cSDH and evaluate its safety, efficacy, indications, and feasibility.Methods: We systematically reviewed the literature according to the PRISMA guidelines using an electronic database. The search yielded 43 articles involving 2,783 patients who underwent MMAE.Results: The hematoma resolution, recurrence, and retreatment rates in the MMAE-alone treatment group (n = 815) were 86.7%, 6.3%, and 9.6%, respectively, whereas those in the prophylactic MMAE with combined surgery group (n = 370) were 95.6%, 4.4%, and 3.4%, respectively. The overall MMAE-related complication rate was 2.3%.Conclusion: This study shows that MMAE alone is, although not immediate, as effective as evacuation surgery alone in reducing hematoma. The study also shows that combined treatment has a lower recurrence rate than evacuation surgery alone. Because MMAE is a safe procedure, it should be considered for patients with cSDH, especially those with a high risk of recurrence.


  • Application of protective superficial temporal artery to middle cerebral artery bypass through the lateral supraorbital approach: Technical note

    by Taichi Ishiguro, Akitsugu Kawashima, Shunsuke Nomura, Behnam Rezai Jahromi, Hugo Andrade-Barazarte, Juha A. Hernesniemi, Takakazu Kawamata